首页 › 股票 › THRD

THRD — THIRD HARMONIC BIO INC

申报持仓市值$409.21M
持有基金数(最新)180
板块—

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)3
机构持仓市值$109.99K · 20.44K 股
新建/增持/减仓/清仓0 / 0 / 0 / 1 · 更新于 2026-11-13
前五大/前十大集中度100.0% / 100.0%
机构整体持仓变动 增持 +0.0% (+0 股)
机构持仓市值变动 上升 +0.0%

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 3 家机构在其最新 13F 申报中持有 THRD(THIRD HARMONIC BIO INC),合计申报市值 $109.99K,对应 20.44K 股。按股数计算较上季度增持 0.0%(+0 股),申报市值环比上升 0.0%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。

与上一季度相比,1 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

THIRD HARMONIC BIO INC(THRD)的主要机构持有人包括 Atlas Venture Life Science Advisors, LLC、GENERAL ATLANTIC, L.P.、EcoR1 Capital, LLC,按 13F 申报市值在本页 180 家持有人中排名居前。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 2 20.44K $109.95K +0.0%
Q2 2026 3 20.44K $109.99K +0.0%
Q1 2026 4 20.46K $109.99K -1.4%
Q4 2025 4 20.75K $111.54K -2.1%
Q3 2025 13 499.95K $1.19M -6.9%
Q2 2025 111 40.17M $218.06M +7.0%
Q1 2025 100 39.33M $136.46M +5.1%
Q4 2024 100 46.04M $470.00M +1.0%

表内 8 个季度中,机构持股合计减少 100%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+7.0%)。

前 25 大机构持仓人(Q3 2026) — 2 家基金

基金股数金额组合权重变化
RHUMBLINE ADVISERS 19.98K $107.49K 0.00% 持有
GAMMA Investing LLC 458 $2.46K 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 3 家基金

基金股数金额组合权重变化
RHUMBLINE ADVISERS 19.98K $107.49K 0.00% 持有
GAMMA Investing LLC 458 $2.46K 0.00% 持有
HUNTINGTON NATIONAL BANK 1 $41 0.00% 持有

Q1 2026 — 4 家基金

基金股数金额组合权重变化
RHUMBLINE ADVISERS 19.98K $107.49K 0.00% 减持
GAMMA Investing LLC 458 $2.46K 0.00% 持有
HUNTINGTON NATIONAL BANK 1 $41 0.00% 持有
SBI Securities Co., Ltd. 20 $1 0.00% 持有

Q4 2025 — 4 家基金

基金股数金额组合权重变化
RHUMBLINE ADVISERS 20.27K $109.03K 0.00% 减持
GAMMA Investing LLC 458 $2.46K 0.00% 持有
HUNTINGTON NATIONAL BANK 1 $41 0.00% 持有
SBI Securities Co., Ltd. 20 $1 0.00% 持有

Q3 2025 — 13 家基金

基金股数金额组合权重变化
DIMENSIONAL FUND ADVISORS LP 93.94K $505.39K 0.00% 持有
CANTOR FITZGERALD, L. P. 86.33K $464.43K 0.01% 新进
RHUMBLINE ADVISERS 20.71K $111.40K 0.00% 减持
MetLife Investment Management, LLC 16.86K $90.70K 0.00% 持有
JBF Capital, Inc. 250.00K $7.50K 0.00% 新进
Russell Investments Group, Ltd. 803 $4.32K 0.00% 增持
AMALGAMATED BANK 665 $4.00K 0.00% 持有
GAMMA Investing LLC 458 $2.46K 0.00% 增持
Optiver Holding B.V. 196 $1.05K 0.00% 新进
Nuveen, LLC 27.96K $839 0.00% 持有
Ameritas Investment Partners, Inc. 2.02K $61 0.00% 持有
HUNTINGTON NATIONAL BANK 1 $41 0.00% 持有
SBI Securities Co., Ltd. 20 $1 0.00% 持有

Q2 2025 — 25 家基金

基金股数金额组合权重变化
Atlas Venture Life Science Advisors, LLC 10.40M $56.48M 8.53% 持有
ORBIMED ADVISORS LLC 5.78M $31.38M 0.82% 持有
BML Capital Management, LLC 3.82M $20.77M 15.71% 持有
Nantahala Capital Management, LLC 2.94M $15.96M 0.71% 持有
TCG Crossover Management, LLC 1.92M $10.40M 1.19% 减持
BlackRock Inc 1.73M $9.38M 0.00% 增持
Vanguard Group 1.30M $7.05M 0.00% 增持
D. E. Shaw & Co., Inc. 1.25M $6.79M 0.02% 增持
D. E. Shaw & Co 1.25M $6.79M 0.01% 增持
TANG CAPITAL MANAGEMENT LLC 929.73K $5.05M 0.26% 持有
Schonfeld Strategic Advisors LLC 770.80K $4.19M 0.04% 增持
ADAR1 Capital Management, LLC 622.87K $3.38M 0.56% 增持
Geode Capital Management 577.19K $3.13M 0.00% 增持
DLD Asset Management, LP 503.84K $2.74M 0.36% 新进
STATE STREET CORP 468.99K $2.55M 0.00% 增持
OMERS ADMINISTRATION Corp 426.90K $2.32M 0.02% 新进
Affinity Asset Advisors, LLC 370.00K $2.01M 0.31% 持有
Alpine Global Management, LLC 334.48K $1.82M 0.45% 新进
Yakira Capital Management, Inc. 293.63K $1.59M 0.60% 新进
Rangeley Capital, LLC 290.00K $1.57M 1.96% 增持
Morgan Stanley 272.47K $1.48M 0.00% 减持
GABELLI & Co INVESTMENT ADVISERS, INC. 251.68K $1.37M 0.21% 新进
Alberta Investment Management Corp 239.39K $1.30M 0.01% 新进
Vazirani Asset Management LLC 225.50K $1.22M 4.68% 增持
Goldman Sachs Group 221.09K $1.20M 0.00% 增持

查看全部 180 家持有基金 →

新建仓(Q2 2026)

本季度没有基金新建该仓位。

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
RHUMBLINE ADVISERS 19.98K 19.98K 19.98K 20.27K 20.71K 33.67K 28.17K 28.92K 28.72K 28.60K 20.66K 19.77K 18.63K — — — —
GAMMA Investing LLC 458 458 458 458 458 105 — 97 120 113 97 77 — — — — —
Atlas Venture Life Science Advisors, LLC — — — — — 10.40M 10.40M 10.40M 10.91M 10.91M 10.91M 10.91M 10.91M — — — —
ORBIMED ADVISORS LLC — — — — — 5.78M 5.78M 5.78M 5.78M 5.78M 5.78M 5.78M 5.78M — — — —
BVF INC/IL — — — — — — 2.37M 2.37M 4.37M 4.37M 4.37M 4.37M 4.37M — — — —
EcoR1 Capital, LLC — — — — — — — 3.18M 3.18M 3.18M 3.18M 3.18M 2.98M — — — —
GENERAL ATLANTIC, L.P. — — — — — — — 3.37M 2.96M 2.96M 2.96M 2.96M 2.96M — — — —
T. Rowe Price Investment Management, Inc. — — — — — — — 2.93M 2.83M 1.35M — — — — — — —
TCG Crossover Management, LLC — — — — — 1.92M 2.51M 2.51M 2.42M — — — — — — — —
RA CAPITAL MANAGEMENT, L.P. — — — — — — — 960.62K 1.28M 2.03M 2.03M 2.03M 961.86K — — — —
Fidelity Management & Research (FMR) — — — — — 4.41K 1.07K 2.54M 307.99K 3.74K 3.77K 3.72K 3.44K 2.75K 981 109 —
BML Capital Management, LLC — — — — — 3.82M 3.82M — — — — — — — — — —
Boxer Capital Management, LLC — — — — — — — 2.00M — — — — — — — — —
Commodore Capital LP — — — — — — — 237.70K 1.36M 1.55M 1.25M 706.71K 1.70M — — — —
BlackRock Inc — — — — — 1.73M 1.48M 1.48M 1.46M — — — — — — — —
Nantahala Capital Management, LLC — — — — — 2.94M 2.94M 501.00K — — — — — — — — —
BRAIDWELL LP — — — — — — — — — — — 1.32M 1.65M — — — —
Vanguard Group — — — — — 1.30M 1.16M 1.03M 891.65K 873.80K 851.39K 839.88K 773.46K 769.84K 747.95K 696.37K 100.00K
TANG CAPITAL MANAGEMENT LLC — — — — — 929.73K 929.73K 150.00K — — — — 1.80M — — — —
JPMorgan Chase & Co — — — — — 95.54K 264.42K 36.15K 13.41K 13.44K 442.14K 1.01M 12.96K 15.52K 61 18.88K —

下载持有人名单 (CSV)

常见问题

Which funds hold THRD?

As of 2026-Q2, 3 institutional funds reported holding THRD (THIRD HARMONIC BIO INC) in SEC 13F filings, with a combined reported value of $109.99K.

How many shares of THRD do institutions own?

13F filers reported 20.44K shares of THRD, worth $109.99K in aggregate at the end of 2026-Q2.

Is institutional ownership of THRD rising or falling?

Share counts moved +0.0% versus the prior quarter — accumulation.

Who are the top institutional holders of THRD?

The largest 13F holders are Atlas Venture Life Science Advisors, LLC, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, T. Rowe Price Investment Management, Inc.; the top 25 are ranked at the top of this page.

Who are the major shareholders of THIRD HARMONIC BIO INC?

The major shareholders of THIRD HARMONIC BIO INC (THRD) by reported 13F value are Atlas Venture Life Science Advisors, LLC, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, T. Rowe Price Investment Management, Inc., among 180 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 THRD」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/THRD/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →